No,구분,개별,평가의뢰일,평가의뢰기관,재평가,평가의뢰종목,법인번호,평가종류,회차,민감도,주기,기준일,평가값송부일,보고서송부일,민감도송부일,평가담당자,공수,전기평가,RM,결과보고서송부,등록월,등록그룹,담당자,연락처,Mail,평가목적,종목등록일
581,-,개별종목,2024-05-23,매커스인베스트먼트,재평가,오에이치코리아,1101113449794 ,A01,0,-,반기 ,2024-06-30,2024-07-10,2024-07-26,-,이상민, 1.0 ,이문수,정재형,정재형,202406,[Y]금융기관,김완기대표 ,"02-2051-8885,010-8743-0685 ",wgkim@makuscrc.com ,회계반영,2
1360,-,기초자산,"삼성증권(PM팀)(구,전략투자팀)펀드(기초자산)",에스비아이-성장사다리코넥스활성화펀드제2호,재평가,앰틱스바이오,1101115734820 ,A01,0,-,분기 ,2024-06-30,2024-07-03,보고서제공X,-,이상민, 0.4 ,이문수,-,-,202406,[6]기타기관펀드(기초자산),0,0,0,-,2
1502,-,기초자산,"삼성증권(PM팀)(구,전략투자팀)펀드(기초자산)",2020IMM벤처펀드,재평가,넥스트바이오메디컬,1201110720228 ,A05,0,-,분기 ,2024-06-30,2024-07-03,보고서제공X,-,이상민, 0.4 ,이문수,-,-,202406,[6]기타기관펀드(기초자산),0,0,0,-,2
1896,-,기초자산,"한화생명보험,현대해상펀드(기초자산)",2018IMM벤처펀드,재평가,넥스트바이오메디컬,1201110720228 ,A01,0,-,분기,2024-06-30,2024-06-14,보고서제공X,-,이상민, - ,이문수,-,-,202406,[6]기타기관펀드(기초자산),0,0,0,-,2
2234,24년 2분기 평가예정,기초자산,미래에셋생명(지분증권)펀드(기초자산),한국투자Re-upII펀드,재평가,"Silverlabs Technologies, Inc.",KBP2022090076,A05,0,-,분기,2024-06-30,2024-06-14,보고서제공X,-,이상민, 0.4 ,이문수,-,-,202406,[6]기타기관펀드(기초자산),0,0,0,-,2
3107,-,개별종목,2024-05-30,키움증권,신규,서지넥스,1101117616315 ,A04,0,Y,분기 ,2024-06-30,2024-07-08,2024-07-16,2024-07-16,이상민, 1.0 ,이문수,오수현,오수현,202406,[Y]금융기관,재무팀이학인과장,02-3787-9741 ,hokijo@kiwoom.com; clark@kiwoom.com; jskim9900@kiwoom.com ,-,2
5825,-,개별종목,2024-06-05,네이버,신규,로앤컴퍼니,1101114928375 ,A01,0,-,반기,2024-06-30,평가철회,평가철회,-,변혜진, - ,변혜진,원정우,원정우,평가철회,평가철회,김병각,"031-784-4211, 010-3080-4775",byunggak.kim@navercorp.com ,-,0
5826,-,개별종목,2024-06-05,네이버,신규,로앤컴퍼니,1101114928375 ,A07,0,-,반기,2024-06-30,평가철회,평가철회,-,변혜진, - ,변혜진,원정우,원정우,평가철회,평가철회,김병각,"031-784-4211, 010-3080-4775",byunggak.kim@navercorp.com ,-,0
5829,-,개별종목,2024-06-05,네이버,재평가,에어스메디컬,1101116843266 ,A00,0,-,반기,2024-06-30,평가철회,평가철회,-,원정우, - ,고명주,원정우,원정우,평가철회,평가철회,김병각,"031-784-4211, 010-3080-4775",byunggak.kim@navercorp.com ,-,0
5830,-,개별종목,2024-06-05,네이버,재평가,에어스메디컬,1101116843266 ,A07,0,-,반기,2024-06-30,평가철회,평가철회,-,원정우, - ,고명주,원정우,원정우,평가철회,평가철회,김병각,"031-784-4211, 010-3080-4775",byunggak.kim@navercorp.com ,-,0
5833,-,개별종목,2024-06-05,네이버,신규,핸디즈,1311110441045 ,A01,0,-,반기,2024-06-30,평가철회,평가철회,-,강성은, - ,강성은,원정우,원정우,평가철회,평가철회,김병각,"031-784-4211, 010-3080-4775",byunggak.kim@navercorp.com ,-,0
5834,-,개별종목,2024-06-05,네이버,신규,핸디즈,1311110441045 ,A07,0,-,반기,2024-06-30,평가철회,평가철회,-,강성은, - ,강성은,원정우,원정우,평가철회,평가철회,김병각,"031-784-4211, 010-3080-4775",byunggak.kim@navercorp.com ,-,0
5836,-,개별종목,2024-06-05,네이버,신규,핸디즈,1311110441045 ,A07,1,-,반기,2024-06-30,평가철회,평가철회,-,강성은, - ,강성은,원정우,원정우,평가철회,평가철회,김병각,"031-784-4211, 010-3080-4775",byunggak.kim@navercorp.com ,-,0
5840,-,개별종목,2024-06-05,네이버,신규,핸디즈,1311110441045 ,A07,2,-,반기,2024-06-30,평가철회,평가철회,-,강성은, - ,강성은,원정우,원정우,평가철회,평가철회,김병각,"031-784-4211, 010-3080-4775",byunggak.kim@navercorp.com ,-,0
5841,-,개별종목,2024-06-05,네이버,재평가,블랭크코퍼레이션,1101115981489 ,A01,0,-,반기,2024-06-30,평가철회,평가철회,-,백형진, - ,백형진,원정우,원정우,평가철회,평가철회,김병각,"031-784-4211, 010-3080-4775",byunggak.kim@navercorp.com ,-,0
5842,-,개별종목,2024-06-05,네이버,재평가,블랭크코퍼레이션,1101115981489 ,A07,0,-,반기,2024-06-30,평가철회,평가철회,-,백형진, - ,백형진,원정우,원정우,평가철회,평가철회,김병각,"031-784-4211, 010-3080-4775",byunggak.kim@navercorp.com ,-,0
5843,-,개별종목,2024-06-05,네이버,재평가,의식주컴퍼니,1101116637768 ,A01,0,-,반기,2024-06-30,평가철회,평가철회,-,서동현, - ,서동현,원정우,원정우,평가철회,평가철회,김병각,"031-784-4211, 010-3080-4775",byunggak.kim@navercorp.com ,-,0
5844,-,개별종목,2024-06-05,네이버,재평가,의식주컴퍼니,1101116637768 ,A05,0,-,반기,2024-06-30,평가철회,평가철회,-,서동현, - ,서동현,원정우,원정우,평가철회,평가철회,김병각,"031-784-4211, 010-3080-4775",byunggak.kim@navercorp.com ,-,0
5861,-,개별종목,2024-06-05,네이버,재평가,Teamblind Inc.,KBP2019060047,A00,0,-,반기,2024-06-30,평가철회,평가철회,-,심태진, - ,심태진,원정우,원정우,평가철회,평가철회,김병각,"031-784-4211, 010-3080-4775",byunggak.kim@navercorp.com ,-,0
5862,-,개별종목,2024-06-05,네이버,재평가,Teamblind Inc.,KBP2019060047,A07,0,-,반기,2024-06-30,평가철회,평가철회,-,심태진, - ,심태진,원정우,원정우,평가철회,평가철회,김병각,"031-784-4211, 010-3080-4775",byunggak.kim@navercorp.com ,-,0
5971,-,개별종목,2024-06-10,카티스,재평가,광옥석재,1412110080237 ,A01,0,-,반기,2024-06-30,2024-07-05,2024-07-12,-,김범준, 1.0 ,김범준,김범준,김범준,202406,[X]일반기업,송미진리더,"02-1644-8411(내선103), 070-4377-5302",mjsl@catis.biz,회계반영,0
5972,-,개별종목,2024-06-10,우리넷,재평가,우리넷,1301110057124 ,D02,3,-,반기 ,2024-06-30,2024-07-10,2024-07-17,-,상장, - ,상장,메자닌평가팀,메자닌평가팀,202406,[W]상장기업,박찬범과장,"031-270-7308, 010-2025-6957",pcb101@woori-net.com,회계반영,0
5973,-,개별종목,2024-06-10,"엑스페릭스(구,슈프리마아이디)",재평가,"엑스페릭스(구,슈프리마아이디)",1311110478436 ,D02,4,Y,반기 ,2024-05-23,2024-06-17,2024-06-24,2024-06-24,상장, - ,상장,메자닌평가팀,메자닌평가팀,202406,[W]상장기업,장태산주임,"1588-8817, 010-9704-5526",taesan@xperix.com,-,0
5974,-,개별종목,2024-06-10,"엑스페릭스(구,슈프리마아이디)",재평가,"엑스페릭스(구,슈프리마아이디)",1311110478436 ,D02,44,Y,반기 ,2024-05-23,2024-06-17,2024-06-24,2024-06-24,상장, - ,상장,메자닌평가팀,메자닌평가팀,202406,[W]상장기업,장태산주임,"1588-8817, 010-9704-5526",taesan@xperix.com,-,0
5975,-,개별종목,2024-06-05,네이버,재평가,인플루엔셜,1101113876327 ,A00,0,-,반기,2024-06-30,2024-07-04,2024-07-11,-,강승현, 1.0 ,강승현,원정우,원정우,202406,[X]일반기업,김병각,"031-784-4211, 010-3080-4775",byunggak.kim@navercorp.com ,-,0
5976,-,개별종목,2024-06-05,네이버,재평가,인플루엔셜,1101113876327 ,A07,1,-,반기,2024-06-30,2024-07-04,2024-07-11,-,강승현, - ,강승현,원정우,원정우,202406,[X]일반기업,김병각,"031-784-4211, 010-3080-4775",byunggak.kim@navercorp.com ,-,0
5977,-,개별종목,2024-06-05,네이버,재평가,수퍼빈,1101115770139 ,A00,0,-,반기,2024-06-30,2024-07-04,2024-07-11,-,김수현, 1.0 ,김수현,원정우,원정우,202406,[X]일반기업,김병각,"031-784-4211, 010-3080-4775",byunggak.kim@navercorp.com ,-,0
5978,-,개별종목,2024-06-05,네이버,재평가,수퍼빈,1101115770139 ,A05,0,-,반기,2024-06-30,2024-07-04,2024-07-11,-,김수현, - ,김수현,원정우,원정우,202406,[X]일반기업,김병각,"031-784-4211, 010-3080-4775",byunggak.kim@navercorp.com ,-,0
5979,-,개별종목,2024-06-05,네이버,재평가,수퍼빈,1101115770139 ,A07,1,-,반기,2024-06-30,2024-07-04,2024-07-11,-,김수현, - ,김수현,원정우,원정우,202406,[X]일반기업,김병각,"031-784-4211, 010-3080-4775",byunggak.kim@navercorp.com ,-,0
5980,-,개별종목,2024-06-05,네이버,재평가,수퍼빈,1101115770139 ,A07,2,-,반기,2024-06-30,2024-07-04,2024-07-11,-,김수현, - ,김수현,원정우,원정우,202406,[X]일반기업,김병각,"031-784-4211, 010-3080-4775",byunggak.kim@navercorp.com ,-,0
5981,-,기초자산,"삼성생명(수익증권),삼성증권(PM팀)(구,전략투자팀)펀드(기초자산)",엠비케이파트너스오호의이사모투자,재평가,Heritage Glamour Holdings Ltd.,KBP2022120202,A01,0,-,분기,2024-06-30,2024-07-02,보고서제공X,-,김예림, 0.4 ,김예림,-,-,202406,[6]기타기관펀드(기초자산),0,0,0,-,0
5982,-,기초자산,"삼성생명(수익증권),삼성증권(PM팀)(구,전략투자팀)펀드(기초자산)",엠비케이파트너스오호의이사모투자,재평가,Aquaman Holdings Limited,KBP2022120203,A01,0,-,분기,2024-06-30,2024-07-02,보고서제공X,-,오영석, 0.4 ,문주현,-,-,202406,[6]기타기관펀드(기초자산),0,0,0,-,0
5983,-,기초자산,"삼성생명(수익증권),삼성증권(PM팀)(구,전략투자팀)펀드(기초자산)",엠비케이파트너스오호의이사모투자,재평가,오스템임플란트,1101111361669 ,A01,0,-,분기,2024-06-30,2024-07-02,보고서제공X,-,서경덕, 0.4 ,서경덕,-,-,202406,[6]기타기관펀드(기초자산),0,0,0,-,0
5984,-,기초자산,"미래에셋생명(지분증권),현대차증권,DB손해보험(구,동부화재해상)펀드(기초자산)",아이엠엠인프라제9호사모투자,신규,에스와이탱크터미널,1101110626139 ,A07,0,-,분기,2024-06-30,2024-06-13,보고서제공X,-,김범준, 0.4 ,허정욱,-,-,202406,[6]기타기관펀드(기초자산),0,0,0,-,1
5985,TRS,개별종목,2024-06-11,이마트에브리데이,재평가,에브리데이리테일제일차,1101140132784 ,A00,0,-,분기 ,2024-06-30,2024-07-02,2024-07-03,-,김영규, 1.0 ,김영규,김영규,김영규,202406,[X]일반기업,김미란매니저,02-380-5940,043750@emarteveryday.co.kr; miran82@emart.com,-,0
5986,TRS,개별종목,2024-06-11,이마트에브리데이,재평가,에브리데이리테일제일차,1101140132784 ,D06,0,-,분기 ,2024-06-30,2024-07-02,2024-07-03,-,김영규, - ,김영규,김영규,김영규,202406,[X]일반기업,김미란매니저,02-380-5940,043750@emarteveryday.co.kr; miran82@emart.com,-,0
5987,TRS,개별종목,2024-06-11,이마트에브리데이,재평가,에브리데이리테일제이차,1101115817626 ,A00,0,-,분기 ,2024-06-30,2024-07-02,2024-07-03,-,김영규, 1.0 ,김영규,김영규,김영규,202406,[X]일반기업,김미란매니저,02-380-5940,043750@emarteveryday.co.kr; miran82@emart.com,-,0
5988,TRS,개별종목,2024-06-11,이마트에브리데이,재평가,에브리데이리테일제이차,1101115817626 ,D06,0,-,분기 ,2024-06-30,2024-07-02,2024-07-03,-,김영규, - ,김영규,김영규,김영규,202406,[X]일반기업,김미란매니저,02-380-5940,043750@emarteveryday.co.kr; miran82@emart.com,-,0
5989,TRS,개별종목,2024-06-11,케이비증권,재평가,에브리데이리테일제일차,1101140132784 ,D06,0,-,분기 ,2024-06-30,2024-07-02,2024-07-03,-,김영규, - ,김영규,김영규,김영규,202406,[Y]금융기관,최지식부장,02-6114-0871,choijisik@kbfg.com,-,0
5990,TRS,개별종목,2024-06-11,케이비증권,재평가,에브리데이리테일제이차,1101115817626 ,D06,0,-,분기 ,2024-06-30,2024-07-02,2024-07-03,-,김영규, - ,김영규,김영규,김영규,202406,[Y]금융기관,최지식부장,02-6114-0871,choijisik@kbfg.com,-,0
5991,-,개별종목,2024-06-11,도우인시스,재평가,도우인시스,1501110134952 ,A00,0,-,분기,2024-05-31,2024-06-27,2024-07-04,-,김범준, 1.0 ,김범준,김범준,김범준,202406,[X]일반기업,김장훈담당자,043-716-2362,janghun.kim@dowooinsys.com,회계반영,0
5992,-,개별종목,2024-06-11,도우인시스,재평가,도우인시스,1501110134952 ,A07,0,-,분기,2024-05-31,2024-06-27,2024-07-04,-,김범준, - ,김범준,김범준,김범준,202406,[X]일반기업,김장훈담당자,043-716-2362,janghun.kim@dowooinsys.com,회계반영,0
5993,2024.06.24 코스닥 상장,개별종목,2024-06-11,IBK투자증권(IPO1팀),신규,한중엔시에스,1701110090291 ,D04,0,-,미정,2024-06-30,2024-07-03,2024-07-10,-,상장, - ,상장,메자닌평가팀,메자닌평가팀,202406,[W]상장기업,이예울대리,02-6915-5337,9m.n-@ibks.com,회계반영,0
5994,-,개별종목,2024-06-11,바디텍메드,재평가,바디텍메드,1101115527168 ,D06,0,-,분기,2024-06-30,2024-07-11,2024-07-22,-,상장, - ,상장,메자닌평가팀,메자닌평가팀,202406,[W]상장기업,김범성차장,070-4495-9374,kbs1@boditech.co.kr,회계반영,0
5995,-,개별종목,2024-06-11,에스케이스퀘어,재평가,에스케이스퀘어,1101118077821 ,D06,0,-,반기,2024-06-28,2024-07-04,2024-07-12,-,상장, - ,상장,메자닌평가팀,메자닌평가팀,202406,[W]상장기업,강민성PL,010-5175-5272,minskang@sk.com,회계반영,0
5996,-,개별종목,2024-06-11,에스케이스퀘어,재평가,에스케이스퀘어,1101118077821 ,D06,1,-,반기,2024-06-28,2024-07-04,2024-07-12,-,상장, - ,상장,메자닌평가팀,메자닌평가팀,202406,[W]상장기업,강민성PL,010-5175-5272,minskang@sk.com,회계반영,0
5997,-,기초자산,"삼성증권(PM팀)(구,전략투자팀)펀드(기초자산)",스마트신세계포커스투자조합,재평가,브레이크앤컴퍼니,1101117764817 ,A07,1,-,분기 ,2024-06-30,2024-07-03,보고서제공X,-,서경덕, - ,서경덕,-,-,202406,[6]기타기관펀드(기초자산),0,0,0,-,0
5998,-,기초자산,"삼성증권(PM팀)(구,전략투자팀)펀드(기초자산)",스마트신세계포커스투자조합,신규,씨엠아이파트너스,1101115812288 ,A07,1,-,분기 ,2024-06-30,2024-07-03,보고서제공X,-,김예림, - ,김예림,-,-,202406,[6]기타기관펀드(기초자산),0,0,0,-,0
5999,-,기초자산,"삼성증권(PM팀)(구,전략투자팀)펀드(기초자산)",스마트신세계포커스투자조합,재평가,"Cipherome, Inc.",KBP2022060186,D02,0,-,분기 ,2024-06-30,2024-07-03,보고서제공X,-,김범준, - ,김범준,-,-,202406,[6]기타기관펀드(기초자산),0,0,0,-,0
6000,"바알리플랫폼 자회사, 2차평가값 : 2024-06-21, 최종평가값 : 2024-06-28(상장종가반영)",개별종목,2024-05-31,KB인베스트먼트,신규,와이어바알리,1101116002466 ,A05,0,-,분기 ,2024-06-30,2024-06-18,2024-07-11,2024-07-17,채동우, 1.0 ,조현우,최수민,최수민,202406,[Y]금융기관,경영기획그룹곽예은계장 ,02-3015-4782 ,ye.kwak@kbfg.com ,-,0
6001,-,기초자산,"롯데손해보험(운용지원팀),한화생명보험,KB손해보험,MG손해보험펀드(기초자산)",엔브이글로벌코리아메자닌사모투자,신규,"다산솔루에타(구,솔루에타)",1351110065750 ,D06,0,-,분기 ,2024-06-30,2024-06-11,보고서제공X,-,상장, - ,상장,-,-,202406,[6]기타기관펀드(기초자산),0,0,0,-,0
6002,-,기초자산,KB손해보험펀드(기초자산),에스지2017사모투자,신규,"GCT Semiconductor, Inc.",KBP2011120050,A01,0,-,분기,2024-06-30,2024-06-11,보고서제공X,-,강승현, - ,강승현,-,-,202406,[6]기타기관펀드(기초자산),0,0,0,-,0
6003,-,기초자산,"DB손해보험(구,동부화재해상)펀드(기초자산)",에이티넘성장투자조합2023,신규,모두싸인,1801111008332 ,A07,0,-,분기,2024-06-30,2024-06-13,보고서제공X,-,오영석, - ,신규,-,-,202406,[6]기타기관펀드(기초자산),0,0,0,-,0
6004,-,기초자산,"DB손해보험(구,동부화재해상)펀드(기초자산)",에이티넘성장투자조합2023,신규,모두싸인,1801111008332 ,A07,1,-,분기,2024-06-30,2024-06-13,보고서제공X,-,오영석, - ,신규,-,-,202406,[6]기타기관펀드(기초자산),0,0,0,-,0
6005,-,기초자산,"DB손해보험(구,동부화재해상)펀드(기초자산)",에이티넘성장투자조합2023,신규,"Pinetree Therapeutics, Inc.",KBP2019120308,A05,0,-,분기,2024-06-30,2024-06-13,보고서제공X,-,백형진, - ,백형진,-,-,202406,[6]기타기관펀드(기초자산),0,0,0,-,0
6006,-,기초자산,"DB손해보험(구,동부화재해상)펀드(기초자산)",에이티넘성장투자조합2023,신규,메디인테크,1357110150608 ,A05,0,-,분기,2024-06-30,2024-06-13,보고서제공X,-,심태진, - ,심태진,-,-,202406,[6]기타기관펀드(기초자산),0,0,0,-,0
6007,-,기초자산,"DB손해보험(구,동부화재해상)펀드(기초자산)",에이티넘성장투자조합2023,신규,아이센스,1101111960924 ,D02,0,-,분기,2024-06-30,2024-06-13,보고서제공X,-,상장, - ,상장,-,-,202406,[6]기타기관펀드(기초자산),0,0,0,-,0
6008,-,기초자산,"DB손해보험(구,동부화재해상)펀드(기초자산)",에이티넘성장투자조합2023,신규,데이터라이즈,1101117195947 ,A07,0,-,분기,2024-06-30,2024-06-13,보고서제공X,-,유재호, - ,유재호,-,-,202406,[6]기타기관펀드(기초자산),0,0,0,-,0
6009,-,기초자산,"DB손해보험(구,동부화재해상)펀드(기초자산)",에이티넘성장투자조합2023,신규,큐픽스,1101115812733 ,A01,0,-,분기,2024-06-30,2024-06-13,보고서제공X,-,신원준, - ,신원준,-,-,202406,[6]기타기관펀드(기초자산),0,0,0,-,0
6010,-,기초자산,"DB손해보험(구,동부화재해상)펀드(기초자산)",에이티넘성장투자조합2023,신규,큐픽스,1101115812733 ,A07,0,-,분기,2024-06-30,2024-06-13,보고서제공X,-,신원준, - ,신원준,-,-,202406,[6]기타기관펀드(기초자산),0,0,0,-,0
6011,-,기초자산,"DB손해보험(구,동부화재해상)펀드(기초자산)",에이티넘성장투자조합2023,신규,먼데이오프,1101117737781 ,A07,0,-,분기,2024-06-30,2024-06-13,보고서제공X,-,변혜진, - ,변혜진,-,-,202406,[6]기타기관펀드(기초자산),0,0,0,-,0
6012,-,개별종목,2024-06-11,신테카바이오,재평가,신테카바이오,1101114179457 ,D02,3,-,반기 ,2024-04-26,2024-06-18,2024-06-25,-,상장, - ,상장,메자닌평가팀,메자닌평가팀,202406,[W]상장기업,양아영과장,"070-7683-1408, 010-4760-3756 ",yay@syntekabio.com ,회계반영,0
6013,-,개별종목,2024-06-11,신테카바이오,재평가,신테카바이오,1101114179457 ,D02,33,-,반기 ,2024-04-26,2024-06-18,2024-06-25,-,상장, - ,상장,메자닌평가팀,메자닌평가팀,202406,[W]상장기업,양아영과장,"070-7683-1408, 010-4760-3756 ",yay@syntekabio.com ,회계반영,0
6014,-,개별종목,2024-06-11,티에스인베스트먼트,재평가,티에스인베스트먼트,1101113840843 ,D02,3,-,반기 ,2024-06-28,2024-07-03,2024-07-05,-,상장, - ,상장,유재호,유재호,202406,[Y]금융기관,임혁빈부장,02-6250-5705,imhb@tsinvestment.co.kr,-,0
6015,-,개별종목,2024-06-11,티에스인베스트먼트,재평가,오디텍,2149110013103 ,D02,1,-,반기 ,2024-06-30,2024-07-03,2024-07-05,-,상장, - ,상장,유재호,유재호,202406,[Y]금융기관,임혁빈부장,02-6250-5705,imhb@tsinvestment.co.kr,-,0
6016,-,개별종목,2024-06-11,티에스인베스트먼트,신규,압타바이오,1358110168906 ,D02,0,-,반기 ,2024-06-30,2024-07-03,2024-07-05,-,상장, - ,상장,유재호,유재호,202406,[Y]금융기관,임혁빈부장,02-6250-5705,imhb@tsinvestment.co.kr,-,0
6017,-,개별종목,2024-06-11,티에스인베스트먼트,신규,압타바이오,1358110168906 ,A07,0,-,반기 ,2024-06-30,2024-07-03,2024-07-05,-,상장, - ,상장,유재호,유재호,202406,[Y]금융기관,임혁빈부장,02-6250-5705,imhb@tsinvestment.co.kr,-,0
6018,-,개별종목,2024-06-11,티에스인베스트먼트,재평가,티라유텍,1101113516105 ,A07,0,-,반기 ,2024-06-30,2024-07-03,2024-07-05,-,상장, - ,상장,유재호,유재호,202406,[Y]금융기관,임혁빈부장,010-2247-5835,imhb@tsinvestment.co.kr,-,0
6019,-,개별종목,2024-06-11,티에스인베스트먼트,신규,도프,1358110267584 ,A07,0,-,반기 ,2024-06-30,2024-07-02,2024-07-05,-,이문수, 1.0 ,이문수,유재호,유재호,202406,[Y]금융기관,임혁빈부장,010-2247-5835,imhb@tsinvestment.co.kr,-,0
6020,-,개별종목,2024-06-11,티에스인베스트먼트,신규,도프,1358110267584 ,A07,1,-,반기 ,2024-06-30,2024-07-02,2024-07-05,-,이문수, - ,이문수,유재호,유재호,202406,[Y]금융기관,임혁빈부장,010-2247-5835,imhb@tsinvestment.co.kr,-,0
6021,-,개별종목,2024-06-11,티에스인베스트먼트,신규,지니웍스,1101115738236 ,A07,0,-,반기 ,2024-06-30,2024-07-02,2024-07-05,-,이문수, 1.0 ,이문수,유재호,유재호,202406,[Y]금융기관,임혁빈부장,010-2247-5835,imhb@tsinvestment.co.kr,-,0
6022,-,개별종목,2024-06-11,티에스인베스트먼트,신규,브라이토닉스이미징,1101116217552 ,A07,0,-,반기 ,2024-06-30,2024-07-02,2024-07-05,-,이진주, 1.0 ,이진주,유재호,유재호,202406,[Y]금융기관,임혁빈부장,010-2247-5835,imhb@tsinvestment.co.kr,-,0
6023,-,개별종목,2024-06-11,티에스인베스트먼트,신규,디파이브테라퓨틱스,1311110624568 ,A07,0,-,반기 ,2024-06-30,2024-07-02,2024-07-05,-,윤광일, 1.0 ,윤광일,유재호,유재호,202406,[Y]금융기관,임혁빈부장,010-2247-5835,imhb@tsinvestment.co.kr,-,0
6024,-,개별종목,2024-06-11,티에스인베스트먼트,신규,글로우서울,1101116710209 ,A07,0,-,반기 ,2024-06-30,2024-07-02,2024-07-05,-,원정우, 1.0 ,원정우,유재호,유재호,202406,[Y]금융기관,임혁빈부장,010-2247-5835,imhb@tsinvestment.co.kr,-,0
6025,-,개별종목,2024-06-11,티에스인베스트먼트,신규,넥스아이,1101117849370 ,A07,0,-,반기 ,2024-06-30,2024-07-02,2024-07-05,-,강성은, 1.0 ,강성은,유재호,유재호,202406,[Y]금융기관,임혁빈부장,010-2247-5835,imhb@tsinvestment.co.kr,-,0
6026,-,개별종목,2024-06-11,티에스인베스트먼트,재평가,엠지알브이,1101116881935 ,A07,0,-,반기 ,2024-06-30,2024-07-02,2024-07-05,-,조현우, 1.0 ,조현우,유재호,유재호,202406,[Y]금융기관,임혁빈부장,010-2247-5835,imhb@tsinvestment.co.kr,-,0
6027,-,개별종목,2024-06-11,티에스인베스트먼트,신규,브로드씨엔에스,1101115083409 ,A07,0,-,반기 ,2024-06-30,2024-07-02,2024-07-05,-,채동우, 1.0 ,채동우,유재호,유재호,202406,[Y]금융기관,임혁빈부장,010-2247-5835,imhb@tsinvestment.co.kr,-,0
6028,-,개별종목,2024-06-11,티에스인베스트먼트,신규,에스씨바이오,1601110606751 ,A07,0,-,반기 ,2024-06-30,2024-07-02,2024-07-05,-,정은채, 1.0 ,정은채,유재호,유재호,202406,[Y]금융기관,임혁빈부장,010-2247-5835,imhb@tsinvestment.co.kr,-,0
6029,-,개별종목,2024-06-11,티에스인베스트먼트,신규,나니아랩스,1601110625628 ,A07,0,-,반기 ,2024-06-30,2024-07-02,2024-07-05,-,백형진, 1.0 ,백형진,유재호,유재호,202406,[Y]금융기관,임혁빈부장,010-2247-5835,imhb@tsinvestment.co.kr,-,0
6030,-,개별종목,2024-06-11,티에스인베스트먼트,신규,위메프오,1101117639119 ,A07,0,-,반기 ,2024-06-30,2024-07-02,2024-07-05,-,심태진, 1.0 ,심태진,유재호,유재호,202406,[Y]금융기관,임혁빈부장,010-2247-5835,imhb@tsinvestment.co.kr,-,0
6031,-,개별종목,2024-06-11,비씨카드,재평가,"티머니(구,한국스마트카드)",1101112869430 ,A01,0,Y,분기 ,2024-06-30,2024-07-02,2024-07-17,-,김수현, 1.0 ,김수현,정은채,정은채,202406,[Y]금융기관,최경수과장,02-520-4959,kychoi@bccard.com,회계반영 ,0
6032,-,개별종목,2024-06-11,비씨카드,재평가,케이리얼티제10호위탁관리부동산투자회사,1101116993483 ,B06,0,Y,분기 ,2024-06-30,2024-07-02,2024-07-17,-,정은채, 1.0 ,정은채,정은채,정은채,202406,[Y]금융기관,최경수과장,02-520-4959,kychoi@bccard.com,회계반영 ,0
6033,-,기초자산,KDB생명보험(수익증권)수익증권(기초자산),한국투자성장기업전문투자형사모혼합자산투자신탁3호1종,재평가,리디,1101113870098 ,A01,0,-,분기 ,2024-06-30,2024-07-04,보고서제공X,-,정은채, 0.4 ,정은채,-,-,202406,[U]기타보험기관(기초자산),0,0,0,-,0
6034,-,기초자산,KDB생명보험(수익증권)수익증권(기초자산),한국투자성장기업전문투자형사모혼합자산투자신탁3호1종,재평가,"뉴넥스(구,브랜디)",1101115587592 ,A01,0,-,분기 ,2024-06-30,2024-07-04,보고서제공X,-,신원준, - ,조현우,-,-,202406,[U]기타보험기관(기초자산),0,0,0,-,0
6035,-,기초자산,KDB생명보험(수익증권)수익증권(기초자산),한국투자성장기업전문투자형사모혼합자산투자신탁3호1종,재평가,"뉴넥스(구,브랜디)",1101115587592 ,A05,6,-,분기 ,2024-06-30,2024-07-04,보고서제공X,-,신원준, - ,조현우,-,-,202406,[U]기타보험기관(기초자산),0,0,0,-,0
